06/16/21 6:30 AMNYSE : TFX New Data Suggest Men with Urinary Symptoms Often Anticipate Bathroom Needs and Avoid Events and Activities They EnjoyTeleflex Incorporated (NYSE: TFX) today announced results of a new survey showing that men with urinaryRHEA-AIneutral
06/07/21 6:30 AMNYSE : TFX conferencesTeleflex to Present at the Raymond James 2021 Human Health Innovation ConferenceThomas Powell, Executive Vice President and Chief Financial Officer, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 2021 Human Health Innovation Conference on Monday, June 21, 2021 at 8:40 a.m. (ET). A live audio webcastRHEA-AIneutral
05/18/21 6:30 AMNYSE : TFX Teleflex Signs Definitive Agreement to Sell Certain Respiratory Assets and Reaffirms Adjusted EPS GuidanceTotal consideration is $286 million, reduced by $12 million of working capital to be retained by Teleflex Assets to be divested generated $139M in 2020 revenue, with 2021 growth expected to be approximately flat 2021 headwinds are estimated at $28-32 million in revenue and $0.10-$0.15 in adjustedRHEA-AIneutral
05/11/21 6:30 AMNYSE : TFX conferencesTeleflex to Present at the UBS Global Healthcare Virtual ConferenceMay 11, 2021 – Thomas Powell, Executive Vice President and CFO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the UBS Global Healthcare Virtual Conference on Tuesday, May 25, 2021 at 3:00 p.m. (ET). A live audio webcast of the conferenceRHEA-AIneutral
05/03/21 6:30 AMNYSE : TFX dividendsTeleflex Announces Quarterly DividendTeleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 15, 2021 to shareholders of record at the close ofRHEA-AIneutral
04/29/21 6:30 AMNYSE : TFX Teleflex Reports First Quarter 2021 ResultsFirst quarter 2021 revenues of $633.9 million, up 0.5% versus prior year period on an as-reported basis; down 2.6% on a constant currency basis First quarter 2021 GAAP diluted EPS from continuing operations of $1.58, compared to $2.78 in the prior year period First quarter 2021 adjusted diluted EPSRHEA-AInegative
04/27/21 6:30 AMNYSE : TFX conferencesTeleflex to Present at the Bank of America Securities 2021 Virtual Health Care ConferenceLiam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Bank of America Securities 2021 Virtual Health Care Conference on Tuesday, May 11, 2021 at 8:00 a.m. (ET). A live audio webcast of the conferenceRHEA-AIneutral
04/15/21 6:30 AMNYSE : TFX earningsTeleflex Announces First Quarter 2021 Earnings Conference Call InformationTeleflex Incorporated (NYSE: TFX) announced today that financial results for the first quarter 2021 will be released before market open on Thursday, April 29, 2021. An investorRHEA-AIneutral
03/10/21 6:30 AMNYSE : TFX conferencesTeleflex to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor ForumJake Elguicze, Treasurer and Vice President of Investor Relations, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on Wednesday, March 24, 2021 at 9:15am (ET). A liveRHEA-AIneutral
03/09/21 6:30 AMNYSE : TFX Teleflex Reports 250,000 Patients Treated for Enlarged Prostate With the Minimally Invasive UroLift® SystemTeleflex Incorporated (NYSE: TFX) today announced that, globally, 250,000 patients have been treated with the UroLift ® System, a proven, minimally invasive approach to treating benign prostatic hyperplasia (BPH). In the United States alone, moreRHEA-AIneutral